EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Crohns disease, infliximab treatment and IgA nephropathy



Crohns disease, infliximab treatment and IgA nephropathy



American Journal of Gastroenterology 98(9 Supplement): S199, September




(PDF emailed within 0-6 h: $19.90)

Accession: 034662484

Download citation: RISBibTeXText

DOI: 10.1016/s0002-9270(03)01371-6



Related references

Effects of antibodies to infliximab on safety and efficacy of infliximab treatment in patients with Crohns disease. Gastroenterology 122(4 Suppl 1): A 613-A 614, April, 2002

Effect of antibodies to infliximab on infusion reaction and clinical response in patients with fistulizing crohns disease receiving maintenance treatment with infliximab. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1598, 2003

Treatment of cutaneous Crohns disease with infliximab. American Journal of Gastroenterology 98(9 Supplement): S250-S251, September, 2003

Successful treatment of esophageal Crohns disease with infliximab. American Journal of Gastroenterology 95(9): 2419, September, 2000

Infliximab for treatment of perineal metastatic Crohns disease. Gastroenterology 118(4 Suppl 2 Part 1): AGA A588, April, 2000

Infliximab therapy for Crohns disease The Crohns and colitis center of New Jersey experience. Gastroenterology 118(4 Suppl 2 Part 2): AGA A1334, April, 2000

Value of MRI in the assessing the response of fistulating Crohns disease to treatment with infliximab. Gastroenterology 122(4 Suppl 1): A 617, April, 2002

Treatment of Pyoderma gangrenosum complicating Crohns disease with infliximab. Gastroenterology 120(5 Supplement 1): A 621, April, 2001

Efficacy of infliximab in the treatment of korean patients with crohns disease. Korean Journal of Gastroenterology 54(2): 108-116, 2009

Treatment of peristomal pyoderma gangrenosum associated with Crohns disease with infliximab. American Journal of Gastroenterology 98(9 Supplement): S175, September, 2003

Infliximab treatment in Crohns disease and antinuclear antibody formation. Gastroenterology 120(5 Supplement 1): A 69, April, 2001

Infliximab for the treatment of entero-vesical fistula in Crohns disease. American Journal of Gastroenterology 98(9 Supplement): S145, September, 2003

Retinal vein thrombosis after infliximab treatment for Crohns disease. American Journal of Gastroenterology 98(4): 939-940, April, 2003

A multicenter study of infliximab in the treatment of children with active Crohns disease. Gastroenterology 116(4 PART 2): A665, April, 1999